Vimarsana
Biggest News Aggregation in the World

Andy Dsilva News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Andy Dsilva. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Andy Dsilva Today - Breaking & Trending Today

OptimizeRx Named America's Fastest-Growing Company for Fifth Year in a Row - Vimarsana News

OptimizeRx Named America's Fastest-Growing Company for Fifth Year in a Row

OptimizeRx Named America's Fastest-Growing Company for Fifth Year in a Row

OptimizeRx Announces Strategic Board Changes to Support Growth and Evolving Landscape - Vimarsana News

OptimizeRx Announces Strategic Board Changes to Support Growth and Evolving Landscape

WALTHAM, Mass., Jan. 25, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals

OptimizeRx Announces Completion of Medicx Acquisition and Sets Third Quarter 2023 Conference Call for November 6, 2023, at 8:30 a.m. ET -October 25, 2023 at 07:31 am EDT - Vimarsana News

OptimizeRx Announces Completion of Medicx Acquisition and Sets Third Quarter 2023 Conference Call for November 6, 2023, at 8:30 a.m. ET -October 25, 2023 at 07:31 am EDT

WALTHAM, Mass., Oct. 25, 2023 -- OptimizeRx Corp.  , the leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals and...

OptimizeRx : Third quarter 2023 headline numbers to come in ahead of consensus with revenue for OptimizeRx standalone expected to be between $15.2-$15.5 million and non-GAAP net income expected to be $0.6-$1 million - Form 8-K -October 16, 2023 at 04:36 pm EDT - Vimarsana News

OptimizeRx : Third quarter 2023 headline numbers to come in ahead of consensus with revenue for OptimizeRx standalone expected to be between $15.2-$15.5 million and non-GAAP net income expected to be $0.6-$1 million - Form 8-K -October 16, 2023 at 04:36 pm EDT

Third quarter 2023 headline numbers to come in ahead of consensus with revenue for OptimizeRx standalone expected to be between $15.2-$15.5 million and non-GAAP net income expected to be...

OptimizeRx Reports Second Quarter 2023 Financial Results - OptimizeRx (NASDAQ:OPRX) - Vimarsana News

OptimizeRx Reports Second Quarter 2023 Financial Results - OptimizeRx (NASDAQ:OPRX)

– RWD.AI-enabled portion of the core business sees 186% YOY growth during the first half of 2023 – Non-core business is lagging – Total revenue of $13.8 million – GAAP net loss per share of $(0.24)